Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
European Journal of Dermatology : EJD|September 2, 2017
Treatment patterns and outcomes for patients with locally advanced basal cell carcinoma before availability of Hedgehog pathway inhibitors: a retrospective chart reviewJohn T Lear, Nicole Basset-Seguin, Martin Kaatz, et al.
American Journal of Therapeutics|January 14, 2014
Treatment algorithms in stage IV melanomaEnrique Espinosa, Jean-Jacques Grob, Reinhard Dummer, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2015
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guidelinePhilippe Saiag, Jean-Jacques Grob, Celeste Lebbe, et al.
The Lancet. Oncology|November 20, 2016
Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trialsGeorgina V Long, Jean-Jacques Grob, Paul Nathan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012Claus Garbe, Ketty Peris, Axel Hauschild, et al.
Nature Reviews. Disease Primers|May 19, 2016
MelanomaDirk Schadendorf, David E Fisher, Claus Garbe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanomaReinhard Dummer, Axel Hauschild, Juergen C Becker, et al.
The Journal of Investigative Dermatology|April 19, 2013
Evidence of a limited intra-individual diversity of nevi: intuitive perception of dominant clusters is a crucial step in the analysis of nevi by dermatologistsYanal Wazaefi, Caroline Gaudy-Marqueste, Marie-Françoise Avril, et al.
Cancers|April 3, 2021
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic MelanomaFrançoise Gondois-Rey, Magali Paul, Florence Alcaraz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trialMichele Maio, Jean-Jacques Grob, Steinar Aamdal, et al.
Pageof 21